RALEIGH, N.C.; 9/18/23, 2023 – Veranex, the only global, tech-enabled product development services provider focused on the medical technology industry, announces the newest addition to their executive team in Chief Commerical Officer, Ryan Roberts.
Most recently Ryan was the Chief Commercial Officer at Sense Biodetection, a venture-backed molecular diagnostics innovator. Prior, he was a Vice President at Edwards Lifesciences’ Critical Care business, CCO at Astute Medical, and V.P. of CareFusion’s (now BD’s) respiratory technologies business.
Veranex’s Chairman & CEO, Pat Donnelly, shared his excitement about the impactful commercial leader joining the team: “All of us here at Veranex could not be more thrilled to have Ryan Roberts join the leadership team.
“All of us here at Veranex could not be more thrilled to have Ryan Roberts join the leadership team. His dynamic approach to the market and knowledge of the industry across all the service lines provided to our clients here at Veranex is a tremendous addition to the company.”
– Pat Donnelly, Veranex CEO and Chairman
Roberts also shared how eager he is to begin this new journey: “Veranex’s portfolio of conceptualization to commercialization services is unparalleled in the market. I’m enthused about the opportunity we have to accelerate market readiness of meaningful, outcomes-changing technologies for our customers and the caregivers and patients they serve.”
Veranex is the only truly comprehensive, global, tech-enabled service provider dedicated to the medical technology industry. Offering expert guidance from concept through to commercialization and across the development continuum, Veranex enables accelerated speed to market, controlled development costs, development risk mitigation, and accelerated market viability assessment. At every stage, Veranex customers realize efficiencies in cost and time while its integrated and comprehensive solutions unify the entire development process.